Recent studies of TSPO-PET in conjunction with in-depth immunophenotyping suggested [18F]DPA-714 to non-invasively image the degree and heterogeneity of the glioma-associated immunosuppressive tumor microenvironment (TME) in vivo22,23. This evidence concerns the gene TSPO and central nervous system cancer.